Prevention and Treatment of Hyperuricemia in Hematological Malignancies
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma
- Vol. 3, S26-S31
- https://doi.org/10.3816/clm.2002.s.012
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Tumor lysis syndromeSeminars in Hematology, 2001
- Tumor lysis syndrome: pathogenesis and managementPediatric Nephrology, 1995
- Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutationsGene, 1991
- Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemiaMedical and Pediatric Oncology, 1990
- Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: Relationship to acute renal failureThe Journal of Pediatrics, 1986
- Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemiaThe Journal of Pediatrics, 1982
- Renal and Metabolic Complications of Undifferentiated and Lymphoblastic LymphomasMedicine, 1981
- Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy.Journal of Clinical Investigation, 1977
- Inhibition of urate production by allopurinolBiochemical Pharmacology, 1977
- Use of Allopurinol for Prevention and Control of Hyperuricemia in Patients with Neoplastic DiseaseNew England Journal of Medicine, 1966